Abstract

The SLC36 family of transporters consists of four genes, two of which, SLC36A1 and SLC36A2, have been demonstrated to code for human proton-coupled amino acid transporters or hPATs. Here we report the characterization of the fourth member of the family, SLC36A4 or hPAT4, which when expressed in Xenopus laevis oocytes also encodes a plasma membrane amino acid transporter, but one that is not proton-coupled and has a very high substrate affinity for the amino acids proline and tryptophan. hPAT4 in Xenopus oocytes mediated sodium-independent, electroneutral uptake of [(3)H]proline, with the highest rate of uptake when the uptake medium pH was 7.4 and an affinity of 3.13 μM. Tryptophan was also an excellently transported substrate with a similarly high affinity (1.72 μM). Other amino acids that inhibited [(3)H]proline were isoleucine (K(i) 0.23 mM), glutamine (0.43 mM), methionine (0.44 mM), and alanine (1.48 mM), and with lower affinity, glycine, threonine, and cysteine (K(i) >5 mM for all). Of the amino acids directly tested for transport, only proline, tryptophan, and alanine showed significant uptake, whereas glycine and cysteine did not. Of the non-proteogenic amino acids and drugs tested, only sarcosine produced inhibition (K(i) 1.09 mM), whereas γ-aminobutyric acid (GABA), β-alanine, L-Dopa, D-serine, and δ-aminolevulinic acid were without effect on [(3)H]proline uptake. This characterization of hPAT4 as a very high affinity/low capacity non-proton-coupled amino acid transporter raises questions about its physiological role, especially as the transport characteristics of hPAT4 are very similar to the Drosophila orthologue PATH, an amino acid "transceptor" that plays a role in nutrient sensing.

Highlights

  • We describe the results of experiments that characterize the function of hPAT4 (SLC36A4) when heterologously expressed in Xenopus laevis oocytes and show for the first time that it is an amino acid transporter with a very high affinity for proline and tryptophan

  • Inhibition of Proline Uptake through hPAT4 by Other Amino Acids—To determine the full substrate range of hPAT4, all of the proteogenic amino acids and D-serine were tested at a single, high concentration (5 mM except for where limited by solubility)

  • The fractional inhibition of hPAT4mediated L-[3H]proline uptake is shown in Fig. 3B, with the amino acids that statistically inhibited uptake being alanine (p Ͻ 0.001, one-sample t test; n ϭ 5 oocyte preparations), isoleucine (p Ͻ 0.05, n ϭ 3), methionine (p Ͻ 0.05, n ϭ 3), tryptophan (p Ͻ 0.01, n ϭ 3), threonine (p Ͻ 0.001, n ϭ 6), glutamine (p Ͻ 0.05, n ϭ 3), and cysteine (p Ͻ 0.05, n ϭ 6)

Read more

Summary

EXPERIMENTAL PROCEDURES

All chemicals were purchased from Sigma, Poole, UK, unless otherwise stated. All experiments were performed at room temperature. Subcloning of the hPAT4 Gene into the Xenopus Oocyteoptimized Vector—The hPAT4 clone was purchased from Geneservice Ltd. (Cambridge, UK, clone ID 5313230) in the JANUARY 28, 2011 VOLUME 286 NUMBER 4. Comparison of transport properties of hPAT1, hPAT2, and hPAT4 ND, no data available

Tryptophan transport
Yes ND
RESULTS
DISCUSSION
Samyuktha Muralidharan Pillai and David Meredith
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call